Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.29% | 73.88 | 0.9% | $406.87m | |
| AMGN | Amgen Inc. | 0.43% | 203.20 | 1.2% | $406.65m | |
| CELG | Celgene Corporation | -0.26% | 87.38 | 1.2% | $336.02m | |
| BIIB | Biogen Inc. | 0.60% | 338.91 | 1.2% | $283.91m | |
| ILMN | Illumina, Inc. | -0.15% | 350.37 | 3.5% | $250.99m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.19% | 383.70 | 2.6% | $210.51m | |
| EXAS | Exact Sciences Corporation | 1.90% | 74.14 | 25.3% | $195.91m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.29% | 176.60 | 1.9% | $160.16m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.06% | 151.95 | 16.4% | $125.05m | |
| A | Agilent Technologies, Inc. | 0.93% | 69.57 | 1.5% | $122.17m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.95% | 121.97 | 2.0% | $111.91m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 1.14% | 94.82 | 9.7% | $95.17m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.21% | 99.77 | 4.4% | $93.85m | |
| NKTR | Nektar Therapeutics | -2.81% | 56.69 | 5.6% | $93.02m | |
| VKTX | Viking Therapeutics, Inc. | 0.98% | 19.65 | 0.9% | $89.56m |
Company Profile
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.